Form 10-Q 1RT Acquisition Corp. For: Jun 30
http://archive.fast-edgar.com/20260813/AA22662CLZ22CZ5Z2IZN2ZY2M7AHW222Z28G
Filed on: August 13, 2026
Form SCHEDULE 13G/A Lucid Group, Inc. Filed by: SAUD H R H PRINCE ALWALEED BIN TALAL BIN ABDULAZIZ
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 8-K Cingulate Inc. For: Aug 13
false
0001862150
0001862150
2026-08-13
2026-08-13
0001862150
CING:CommonStockParValue0.0001PerShareMember
2026-08-13
2026-08-13
0001862150
CING:WarrantsExercisableForCommonStockMember
2026-08-13
2026-08-13
... (continue reading...)
Form 6-K BRENX LTD. For: Aug 13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
For the month of August 2026 (Report No. 2)
Commission File Number: 001-41402
BRENX LTD. (Translation of registrant’s name into English)
13 Amal St. 4th Floor, Park Afek Rosh Haayin, 4809249 Israel (Address of principal executive offices)
Form SCHEDULE 13G Chemomab Therapeutics Filed by: Touchstone Global Investments Pty Ltd
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K Suzano S.A. For: Jun 30
-
Form N-PX Dixon Mitchell Investmen For: Jun 30
-
Form 8-K PDS Biotechnology Corp For: Aug 13
-
Form 10-Q SPAR Group, Inc. For: Jun 30
-
Form 13F-HR Carmignac Gestion For: Jun 30
-
Form 10-Q FATE THERAPEUTICS INC For: Jun 30
-
Form 10-Q Ovid Therapeutics Inc. For: Jun 30
-
Form 13F-HR Dixon Mitchell Investmen For: Jun 30
-
Form 13F-HR Sandhill Capital Partner For: Jun 30
-
Form 10-Q HeartCore Enterprises, For: Jun 30
-
Form 8-K Ovid Therapeutics Inc. For: Aug 11
-
Form 8-K FATE THERAPEUTICS INC For: Aug 13
-
Form 10-Q Nakamoto Inc. For: Jun 30
-
Form 10-Q Caring Brands, Inc. For: Jun 30
-
Form 10-Q Candel Therapeutics, For: Jun 30
-
Form 10-Q K2 Capital Acquisition For: Jun 30
-
Form 10-Q DUKE Robotics Corp. For: Jun 30
-
Form 8-K HeartCore Enterprises, For: Aug 13
-
Form 8-K Tron Inc. For: Aug 13
-
Form 8-K SS Innovations Internati For: Aug 13
-
Form 8-K FITLIFE BRANDS, INC. For: Aug 11
-
Form SCHEDULE 13G Research Alliance Corp Filed by: Spruce Street Capital LP
-
Form 6-K Eco Wave Power Global For: Aug 13
-
Form N-PX Pillsbury Lake Capital For: Jun 30
-
Form D/A lmpactA Global Partners
-
Form 8-K Banzai International, For: Aug 13
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 497 JACKSON NATIONAL SEPARAT
-
Form 8-K Ondas Inc. For: Aug 13
-
Form 6-K DEFSEC Technologies Inc. For: Aug 13
-
Form N-PX Varenne Capital Partners For: Jun 30
-
Form 13F-HR Mount Capital Ltd For: Jun 30
-
Form 8-K SONIDA SENIOR LIVING, For: Aug 07
-
Form 4 Cellebrite DI Ltd. For: Aug 12 Filed by: Jewell Marcus
-
Form 13F-HR Crestview Partners IV For: Jun 30
-
Form 8-K Lucid Diagnostics Inc. For: Aug 13
-
Form 10-Q MeiraGTx Holdings plc For: Jun 30
-
Form 13F-HR Crestview Partners III For: Jun 30
-
Form 13F-HR BOWEN HANES & CO INC For: Jun 30
-
Form 144/A CAMTEK LTD Filed by: Eisenberg Moshe
-
Form 13F-HR Crestview Partners II For: Jun 30
-
Form 10-Q NEUROONE MEDICAL TECHNOL For: Jun 30
-
Form 13F-HR Langdon Equity Partners For: Jun 30
-
Form 10-Q National Vision Holdings For: Jul 04
-
Form 10-Q Solo Brands, Inc. For: Jun 30
-
Form 10-Q Pulmatrix, Inc. For: Jun 30
-
Form 13F-HR Yakira Capital Managemen For: Jun 30
-
Form 13F-HR Sienna Gestion For: Jun 30

